Skip to main content
Top
Published in: Acta Diabetologica 5/2012

Open Access 01-10-2012 | Short Communication

Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births

Authors: D. Iafusco, O. Massa, B. Pasquino, C. Colombo, L. Iughetti, C. Bizzarri, C. Mammì, D. Lo Presti, T. Suprani, R. Schiaffini, Colin G. Nichols, L. Russo, V. Grasso, F. Meschi, R. Bonfanti, S. Brescianini, F. Barbetti, The Early Diabetes Study Group of ISPED

Published in: Acta Diabetologica | Issue 5/2012

Login to get access

Abstract

Until early 2000, permanent and transient neonatal diabetes mellitus (NDM), defined as diabetes with onset within 6 weeks from birth that requires insulin therapy for at least 2 weeks, were considered exceedingly rare conditions, with a global incidence of 1:500,000–1:400,000 live births. The new definition of NDM recently adopted, that includes patients with diabetes onset within 6 months of age, has prompted studies that have set the incidence of the permanent form alone between 1:210,000 and 1:260,000 live births. Aim of the present work was to ascertain the incidence of NDM (i.e. permanent + transient form) in Italy for years 2005–2010. Patients referred to the Italian reference laboratory for NDM between years 2005 and 2010 and screened for mutations in common NDM genes (KCNJ11, ABCC8, and INS) and for uniparental isodisomy of chromosome 6 (UDP6) were reviewed. A questionnaire aimed at identifying NDM cases investigated in other laboratories was sent to 54 Italian reference centers for pediatric diabetes. Twenty-seven patients with NDM born between 2005 and 2010 were referred to the reference laboratory. In this group, a mutation of either KCNJ11, ABCC8 or INS was found in 18 patients, and a case with UDP6 was identified. Questionnaires revealed 4 additional cases with transient neonatal diabetes due to UDP6. Incidence of NDM was calculated at 1:90,000 (CI: 1:63,000–1:132,000) live births. Thus, with the definition currently in use, about 6 new cases with NDM are expected to be born in Italy each year.
Literature
2.
go back to reference Murphy R, Ellard S, Hattersley AT (2008) Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract End Met 4:200–213CrossRef Murphy R, Ellard S, Hattersley AT (2008) Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract End Met 4:200–213CrossRef
3.
go back to reference Russo L, Iafusco D, Brescianini S, Nocerino V, Bizzarri C, Toni S, Cerutti F, Monciotti C, Pesavento R, Iughetti L, Bernardini L, Bonfanti R, Gargantini L, Vanelli M, Aguilar-Bryan L, Stazi A, Grasso V, Colombo C, Barbetti F, The Early Diabetes Study Group of ISPED (2011) Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia 54:1693–1701PubMedCrossRef Russo L, Iafusco D, Brescianini S, Nocerino V, Bizzarri C, Toni S, Cerutti F, Monciotti C, Pesavento R, Iughetti L, Bernardini L, Bonfanti R, Gargantini L, Vanelli M, Aguilar-Bryan L, Stazi A, Grasso V, Colombo C, Barbetti F, The Early Diabetes Study Group of ISPED (2011) Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia 54:1693–1701PubMedCrossRef
4.
go back to reference Colombo C, Porzio O, Liu M, Massa O, Vasta M, Salardi S, Beccaria L, Monciotti C, Toni S, Pedersen O, Hansen T, Federici L, Pesavento R, Cadario F, Federici G, Ghirri P, Arvan P, Iafusco D, Barbetti F, The Early onset diabetes Study Group of the Italian Society of Pediatric Endocrinology, Diabetes (SIEDP) (2008) Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 118:2148–2156PubMed Colombo C, Porzio O, Liu M, Massa O, Vasta M, Salardi S, Beccaria L, Monciotti C, Toni S, Pedersen O, Hansen T, Federici L, Pesavento R, Cadario F, Federici G, Ghirri P, Arvan P, Iafusco D, Barbetti F, The Early onset diabetes Study Group of the Italian Society of Pediatric Endocrinology, Diabetes (SIEDP) (2008) Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 118:2148–2156PubMed
5.
go back to reference von Mühlendahl KE, Herkenhoff H (1995) Long-term course of neonatal diabetes. N Engl J Med 333:704–708CrossRef von Mühlendahl KE, Herkenhoff H (1995) Long-term course of neonatal diabetes. N Engl J Med 333:704–708CrossRef
6.
go back to reference Shield JPH, Gardner RJ, Wadsworth EJK, Whiteford ML, James RS, Robinson DO, Baum JD, Temple IK (1997) Aetiopathology and genetic basis of neonatal diabetes. Arch Dis Child 76:F39–F42 Shield JPH, Gardner RJ, Wadsworth EJK, Whiteford ML, James RS, Robinson DO, Baum JD, Temple IK (1997) Aetiopathology and genetic basis of neonatal diabetes. Arch Dis Child 76:F39–F42
7.
go back to reference Metz C, Cavé H, Bertrand AM, Deffert C, Gueguen-Giroux B, Czernichow P, Polak M (2002) Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 141:483–489PubMedCrossRef Metz C, Cavé H, Bertrand AM, Deffert C, Gueguen-Giroux B, Czernichow P, Polak M (2002) Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 141:483–489PubMedCrossRef
8.
go back to reference Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F, The Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology, Diabetology (2002) Permanent diabetes mellitus in the first year of life. Diabetologia 45:798–804PubMedCrossRef Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F, The Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology, Diabetology (2002) Permanent diabetes mellitus in the first year of life. Diabetologia 45:798–804PubMedCrossRef
9.
go back to reference Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JMCL, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shiled JPH, Sumnik Z, van Rhijn A, Wales JKH, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT (2004) Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 gene and permanent neonatal diabetes. N Engl J Med 350:1838–1849PubMedCrossRef Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JMCL, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shiled JPH, Sumnik Z, van Rhijn A, Wales JKH, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT (2004) Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 gene and permanent neonatal diabetes. N Engl J Med 350:1838–1849PubMedCrossRef
10.
go back to reference Massa O, Iafusco D, D’Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo GF, Crinò A, Lorini R, Cerutti F, Vanelli M, Barbetti F, The Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology, Diabetology (2005) KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 25:22–27PubMedCrossRef Massa O, Iafusco D, D’Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo GF, Crinò A, Lorini R, Cerutti F, Vanelli M, Barbetti F, The Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology, Diabetology (2005) KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 25:22–27PubMedCrossRef
11.
go back to reference Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Cljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I (2007) Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276–1282PubMedCrossRef Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Cljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I (2007) Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276–1282PubMedCrossRef
12.
go back to reference Slingerland AS, Shields BM, Flanagan SE, Bruining GJ, Noordam K, Gach A, Mlynarski W, Malecki MT, Hattersley AT, Ellard S (2009) Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 52:1683–1685PubMedCrossRef Slingerland AS, Shields BM, Flanagan SE, Bruining GJ, Noordam K, Gach A, Mlynarski W, Malecki MT, Hattersley AT, Ellard S (2009) Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 52:1683–1685PubMedCrossRef
13.
go back to reference Jarosz-Chobot P, Deja G, Polanska J (2010) Epidemiology of type 1 diabetes among Silesian children aged 0–14 years, 1989–2005. Acta Diabetol 47:29–33PubMedCrossRef Jarosz-Chobot P, Deja G, Polanska J (2010) Epidemiology of type 1 diabetes among Silesian children aged 0–14 years, 1989–2005. Acta Diabetol 47:29–33PubMedCrossRef
14.
go back to reference Flanagan SE, Clauin S, Bellané-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S (2009) Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 30:170–180PubMedCrossRef Flanagan SE, Clauin S, Bellané-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S (2009) Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 30:170–180PubMedCrossRef
15.
go back to reference Prisco F, Iafusco D, Franzese A, Sulli N, Barbetti F (2000) MODY 2 presenting as neonatal hyperglycemia: a need to re-shape the definition of “neonatal diabetes”? Diabetologia 43:1331–1332PubMedCrossRef Prisco F, Iafusco D, Franzese A, Sulli N, Barbetti F (2000) MODY 2 presenting as neonatal hyperglycemia: a need to re-shape the definition of “neonatal diabetes”? Diabetologia 43:1331–1332PubMedCrossRef
16.
go back to reference Grulich-Henn J, Wagner V, Thont A, Schober E, Marg W, Kapellen TM, Haberland H, Raile K, Ellard S, Flanagan SE, Hattersley AT, Holl RW (2010) Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabetic Med 27:709–712PubMedCrossRef Grulich-Henn J, Wagner V, Thont A, Schober E, Marg W, Kapellen TM, Haberland H, Raile K, Ellard S, Flanagan SE, Hattersley AT, Holl RW (2010) Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabetic Med 27:709–712PubMedCrossRef
Metadata
Title
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births
Authors
D. Iafusco
O. Massa
B. Pasquino
C. Colombo
L. Iughetti
C. Bizzarri
C. Mammì
D. Lo Presti
T. Suprani
R. Schiaffini
Colin G. Nichols
L. Russo
V. Grasso
F. Meschi
R. Bonfanti
S. Brescianini
F. Barbetti
The Early Diabetes Study Group of ISPED
Publication date
01-10-2012
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0331-8

Other articles of this Issue 5/2012

Acta Diabetologica 5/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.